Abstract
This study evaluates the long-term clinical outcome of 56 consecutive patients affected by atrial fibrillation and drug-related typical atrial flutter who underwent cavo-tricuspid isthmus radiofrequency ablation. Symptomatic arrhythmic events recurred after ablation in 64% of the patients during follow-up of 19 +/- 9 months. Even in those who had recurrences, there was a substantial reduction in the incidence of episodes, quality of life was improved, and hospitalizations decreased.
MeSH terms
-
Aged
-
Anti-Arrhythmia Agents / adverse effects*
-
Anti-Arrhythmia Agents / therapeutic use
-
Atrial Fibrillation / drug therapy*
-
Atrial Flutter / chemically induced*
-
Atrial Flutter / surgery*
-
Catheter Ablation / methods*
-
Electrocardiography / drug effects
-
Female
-
Follow-Up Studies
-
Humans
-
Male
-
Middle Aged
-
Patient Readmission / statistics & numerical data
-
Postoperative Complications / etiology*
-
Quality of Life
-
Recurrence
-
Tricuspid Valve / surgery*
-
Vena Cava, Superior / surgery*